Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Johnson and Johnson

Last Updated: January 26, 2022

Volunteer for clinical trials for PROGESTERONE at ClinicalTrialExchange

DrugPatentWatch Database Preview

PROGESTERONE Drug Patent Profile

Email this page to a colleague

« Back to Dashboard

When do Progesterone patents expire, and what generic alternatives are available?

Progesterone is a drug marketed by Amneal Pharms Ny, Bionpharma Inc, Dr Reddys, Eugia Pharma, Sofgen Pharms, Teva Pharms, Xiromed, Actavis Labs Ut Inc, Am Regent, Fresenius Kabi Usa, Hikma Farmaceutica, and Lilly. and is included in thirteen NDAs.

The generic ingredient in PROGESTERONE is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the progesterone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Progesterone

A generic version of PROGESTERONE was approved as progesterone by FRESENIUS KABI USA on April 25th, 2001.

  Sign up for a Free Trial

Drug patent expirations by year for PROGESTERONE
Drug Prices for PROGESTERONE

See drug prices for PROGESTERONE

Drug Sales Revenue Trends for PROGESTERONE

See drug sales revenues for PROGESTERONE

Recent Clinical Trials for PROGESTERONE

Identify potential brand extensions & 505(b)(2) entrants

University of California, San DiegoPhase 4
AHS Cancer Control AlbertaPhase 2
Laniado HospitalN/A

See all PROGESTERONE clinical trials

Pharmacology for PROGESTERONE
Drug Class Progesterone
Medical Subject Heading (MeSH) Categories for PROGESTERONE

US Patents and Regulatory Information for PROGESTERONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Ny PROGESTERONE progesterone CAPSULE;ORAL 207724-001 Sep 7, 2017 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Fresenius Kabi Usa PROGESTERONE progesterone INJECTABLE;INJECTION 075906-001 Apr 25, 2001 AO RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Eugia Pharma PROGESTERONE progesterone CAPSULE;ORAL 211285-001 Oct 26, 2018 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Bionpharma Inc PROGESTERONE progesterone CAPSULE;ORAL 200900-002 Aug 16, 2013 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.